Risk factors for symptom recurrence after microwave ablation of adenomyosis: a preliminary retrospective study

Sainan Guan; Yongyan He; Xi Zhou; Jinxiu Wan; Haijing Peng; G X Bu; Guojuan Bu; Shuang Liang; Huahui Liu; Shiying Huang; Erjiao Xu

doi:10.1080/02656736.2024.2429556

Risk factors for symptom recurrence after microwave ablation of adenomyosis: a preliminary retrospective study

Sainan Guan, Yongyan He, Xi Zhou, Jinxiu Wan, Haijing Peng, G X Bu, Guojuan Bu, Shuang Liang, Huahui Liu, Shiying Huang, Erjiao Xu

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2024 · vol. 41(1) , pp. 2429556 · doi:10.1080/02656736.2024.2429556 · PMID:39561985 · W4404513443

article OA: gold CC0 ⤵ 1 in-corpus citation

🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

Abstract

INTRODUCTION: Microwave ablation (MWA) effectively treats adenomyosis, yet symptom recurrence remains challenging. Thus, our study aims to explore the independent risk factors related to symptom recurrence after MWA of symptomatic adenomyosis. MATERIAL AND METHODS: Patients with symptomatic adenomyosis who received MWA treatment at our institute from June 2020 to June 2023 were retrospectively included. Preoperative and intraoperative clinical data were retrospectively collected, and symptom relief following MWA was systematically monitored. Independent risk factors for symptom recurrence after MWA of adenomyosis were explored through Cox regression analysis. Kaplan-Meier (K-M) curves were plotted to estimate recurrence-free survival, and differences between groups were analyzed using the Log-Rank test. RESULT: ) were independent risk factors for symptom recurrence after MWA of adenomyosis. CONCLUSION: MWA is an effective treatment for relieving symptoms of adenomyosis. While fertility requirements, without artificial ascites assistance, and lower EPV were independent risk factors for symptom recurrence after MWA of adenomyosis.

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Microwaves Microwaves Microwaves Microwaves Microwaves Microwaves Microwaves Microwaves Microwaves

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (21)

Cited by (1)

Artificial intelligence and modern surgical energy-based technologies in the treatment of women of reproductive age with adenomyosis and uterine fibroids (literature review and own data) 2026

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-06-02T00:32:20.209032+00:00

License: CC0 · commercial use OK

[1] Adenomyosis: a systematic review of medical treatment via openalex

[2] Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease via openalex

[3] Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia via openalex

[4] Clinical evaluation of HIFU combined with GnRH-a and LNG-IUS for adenomyosis patients who failed to respond to drug therapies: two-year follow-up results via openalex

[5] Clinical Predictors of Long-term Success in Ultrasound-guided High-intensity Focused Ultrasound Ablation Treatment for Adenomyosis via openalex

[6] Diagnosis, Evaluation, and Treatment of Adenomyosis via openalex

[7] Effects of different treatment methods on clinical efficacy and fertility outcomes of patients with adenomyosis via openalex

[8] Efficacy and safety of magnetic resonance-guided focused ultrasound surgery (MRgFUS) ablation in the management of abnormal uterine bleeding due to uterine leiomyoma or adenomyosis. via openalex

[9] Efficacy and safety of percutaneous microwave ablation for adenomyosis in the posterior uterine wall via openalex

[10] Feasibility study on energy prediction of microwave ablation upon uterine adenomyosis and leiomyomas by MRI via openalex

[11] How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic via openalex

[12] Percutaneous microwave ablation with artificial ascites for symptomatic uterine adenomyosis: initial experience via openalex

[13] Preoperative CA125 as a risk factor for symptom recurrence of adenomyosis after ultrasound-guided high-intensity focused ultrasound ablation surgery via openalex

[14] Principles and clinical applications of ultrasound - guided percutaneous microwave ablation in treatment of adenomyosis via openalex

[15] Risk of Recurrence and Reintervention After Uterine-Sparing Interventions for Symptomatic Adenomyosis via openalex

[16] Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis via openalex

[17] Transvaginal sonographic features of diffuse adenomyosis in 18–30‐year‐old nulligravid women without endometriosis: association with symptoms via openalex

[18] Treatment of adenomyomectomy in women with severe uterine adenomyosis using a novel technique via openalex

[19] W4308979129 via openalex

[20] W2736858912 via openalex

[21] W2158378333 via openalex